Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling

Blood

Volumn 109, Issue 9, 2007, Pages 3922-3928

  Sakhinia, Ebrahim ^a   Glennie, Caroline ^a   Hoyland, Judith A ^a   Menasce, Lia P ^b   Brady, Gerard ^c   Miller, Crispin ^d   Radford, John A ^e   Byers, Richard J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c Epistem Ltd   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN B; HLA DQ ANTIGEN; PROTEIN BCL 6; TRANSCRIPTION FACTOR YY1;

ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; COL3A1 GENE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; H731 GENE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MICROARRAY ANALYSIS; NPM3 GENE; ONCOGENE; OVGL GENE; PREDICTION; PRIORITY JOURNAL; PRKCB1 GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XPB GENE; ZFPC150 GENE;

EID: 34247357360     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-09-046391     Document Type: Article

References (26)

1. Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood. 2004;104:923-932.
2. Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling in follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood. 2002;99:282-289.
3. Rosenwald A, Wright G, Chan W-C, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
4. Shipp M-A, Ross K-N, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68-74.
5. Al-Taher A, Bashein A, Nolan T, Hollingsworth M, Brady G. Global cDNA amplification combined with real-time RT-PCR: accurate quantification of multiple human potassium channel genes at the single cell level. Yeast. 2000;17:201-210.
6. Brady G, Iscove N-N. Construction of cDNA libraries from single cells. Methods Enzymol. 1993;225:611-623.
7. Iscove N-N, Barbara M, Gu M, Gibson M, Modi C, Winegarden N. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat Biotechnol. 2002;20:940-943.
8. Brail L-H, Jang A, Billia F, Iscove N-N, Klamut H-J, Hill R-P. Gene expression in individual cells: analysis using global single cell reverse transcription polymerase chain reaction (GSC RT-PCR). Mutat Res.1999;406:45-54.
9. Byers R, Roebuck J, Sakhinia E, Hoyland J. PolyA PCR amplification of cDNA from RNA extracted from formalin-fixed paraffin-embedded tissue. Diagn Mol Pathol. 2004;13:144-50.
10. Sakhinia E, Farahanpour M, Liu Yin J-A, Brady G, Hoyland J-A, Byers R-J. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow. Br J Haematol. 2005;130:233-248.
11. Brady G. Expression profiling of single mammalian cells: small is beautiful. Yeast. 2000;17:211-217.
12. Brady G, Barbara M, Iscove N-N. Representative in vitro cDNA amplification from individual haemopoietic cells and colonies. Methods Mol Cell Biol. 1990;17.
13. Gentleman R-C, Carey V-J, Bates D-M, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
14. Tusher V-G, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-5121.
15. Okuda M, Horn H-F, Tarapore P, et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 2000;103:127-140.
16. Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, Knuutila S. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet. 2001;128:1-6.
17. Troen G, Nygaard V, Jenssen T-K, et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn. 2004;6:297-307.
18. Jordanova E-S, Philippo K, Giphart M-J, Schuuring E, Kluin P-M. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma. Immunogenetics. 2003;55:203-209.
19. Dave S-S, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159-2169.
20. Woo M-M, Gilks C-B, Verhage H-G, Longacre T-A, Leung P-C, Auersperg N. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts. Gynecol Oncol. 2004;93:315-319.
21. Tricoli J-V, Bracken R-B. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chromosomes Cancer. 1993;6:65-72.
22. Liu X, Huang X, Sigmund CD. Identification of a nuclear orphan receptor (Ear2) as a negative regulator of renin gene transcription. Circ Res. 2003;92:1033-1040.
23. Guo J, Casolaro V, Seto E, et al. Yin-Yang 1 activates interleukin-4 gene expression in T cells. J Biol Chem. 2001;276:48871-48878.
24. Vega M-I, Huerta-Yepez S, Jazirehi A-R, Garban H, Bonavida B. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene. 2005; 24:8114-8127.
25. Vega M-I, Jazirehi A-R, Huerta-Yepez S, Bonavida B. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappaB activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. J Immunol. 2005;175:2174-2183.
26. Hans C-P, Weisenburger D-D, Greiner T-C, et al. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol. 2005;18:1377-1384.